INS and diabetes mellitus: Studies have demonstrated that 4-MU, an inhibitor of hyaluronan synthesis, can significantly reduce the deposition of hyaluronan in the islets of autoimmune diabetic mice, increase the insulin-positive area in the islets, and increase the number of regulatory T cells, thus having the potential to prevent the progression of diabetes [9,42].